Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

LY 163502

Known as: LY-163502 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The new, extremely potent and enantioselective D-2 agonist LY 163502 failed to induce compulsive stereotyped behaviour. Very low… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
1993
1993
In the lateral striatum of aged rats, dopamine D‐2 receptor density is reduced and glutamate tissue content is elevated. D‐2… Expand
1992
1992
The rates and patterns of discharge activity exhibited by 16 spontaneously active substantia nigra pars compacta dopamine neurons… Expand
1992
1992
Administration of the dopamine receptor agonist apomorphine causes a dose-dependent increase in plasma oxytocin concentrations… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Highly Cited
1991
Highly Cited
1991
The D2 dopamine receptor agonist quinelorane (LY-163502), microinjected into the paraventricular nucleus (PVN), affected genital… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
1991
1991
This study investigated the effects on genital reflexes of unilateral MPOA injections of 0.1, 1, 3, and 10 micrograms of the D2… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
1991
1991
Functional interactions between D-1 and D-2 dopamine receptor systems appear important in the regulation of psychomotor behavior… Expand
Highly Cited
1990
Highly Cited
1990
Studies were undertaken to clarify further the mechanism(s) of action of the atypical neuroleptic clozapine, using a behavioural… Expand
1990
1990
Systemic administration of direct and indirect dopamine agonists resulted in increased extracellular ascorbic acid levels in the… Expand
Highly Cited
1989
Highly Cited
1989
The D1/D2 dopamine agonist apomorphine, microinjected into the medial preoptic area (MPOA), facilitates male rat sexual behavior… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3